Evaluating whether to invest in Rocket Pharmaceuticals (NASDAQ: RCKT) requires weighing its innovative pipeline of advanced gene therapies for rare, severe genetic diseases against clinical development timelines and biotech market volatility. What is your specific risk tolerance, portfolio strategy, and investment time horizon? Professional financial guidance is strongly recommended.